Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
18,515
archived clinical trials in
Lymphoma

mi
from
Anderson, SC
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
AnMed Health Medical Center
mi
from
Anderson, SC
mi
from
Florence, SC
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
McLeod Regional Medical Center
mi
from
Florence, SC
mi
from
Spartanburg, SC
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Spartanburg Regional Health Service District
mi
from
Spartanburg, SC
mi
from
Spartanburg, SC
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Upstate Carolina CCOP
mi
from
Spartanburg, SC
mi
from
Knoxville, TN
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Thompson Cancer Survival Center
mi
from
Knoxville, TN
mi
from
San Antonio, TX
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
mi
from
San Antonio, TX
mi
from
San Antonio, TX
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Cancer Therapy and Research Center
mi
from
San Antonio, TX
mi
from
San Antonio, TX
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Puget Sound VA Medical Center
mi
from
Seattle, WA
mi
from
Salt Lake City, UT
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Huntsman Cancer Hospital
mi
from
Salt Lake City, UT
mi
from
Danville, VA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Danville Regional Medical Center
mi
from
Danville, VA
mi
from
Ann Arbor, MI
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
St. Joseph's Hospital
mi
from
Ann Arbor, MI
mi
from
Bremerton, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Olympic Hematology and Oncology
mi
from
Bremerton, WA
mi
from
Centralia, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Providence Centralia Hospital
mi
from
Centralia, WA
mi
from
Federal Way, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
St. Francis Hospital
mi
from
Federal Way, WA
mi
from
Kennewick, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
mi
from
Mount Vernon, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Skagit Valley Hospital Cancer Care Center
mi
from
Mount Vernon, WA
mi
from
Poulsbo, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Harrison Poulsbo Hematology and Onocology
mi
from
Poulsbo, WA
mi
from
Puyallup, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Good Samaritan Cancer Center
mi
from
Puyallup, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
University of Washington; UW Medical Center
mi
from
Seattle, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Minor and James Medical, PLLC
mi
from
Seattle, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Group Health Capitol Hill Campus
mi
from
Seattle, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Swedish Cancer Center
mi
from
Seattle, WA
mi
from
Seattle, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Polyclinic First Hill
mi
from
Seattle, WA
mi
from
Spokane, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Evergreen Hematology & Oncology
mi
from
Spokane, WA
mi
from
Spokane, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Cancer Care Northwest - Spokane South
mi
from
Spokane, WA
mi
from
Tacoma, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
St. Clare Hospital
mi
from
Tacoma, WA
mi
from
Tacoma, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Franciscan Cancer Center at St. Joseph Medical Center
mi
from
Tacoma, WA
mi
from
Tacoma, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Northwest CCOP
mi
from
Tacoma, WA
mi
from
Tacoma, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
MultiCare Regional Cancer Center at Tacoma General Hospital
mi
from
Tacoma, WA
mi
from
Tacoma, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Allenmore Hospital
mi
from
Tacoma, WA
mi
from
Vancouver, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Legacy Salmon Creek Medical Center
mi
from
Vancouver, WA
mi
from
Vancouver, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Southwest Washington Medical Center Cancer Center
mi
from
Vancouver, WA
mi
from
Wenatchee, WA
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
mi
from
Casper, WY
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Rocky Mountain Oncology
mi
from
Casper, WY
mi
from
Sheridan, WY
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
Central Lymphoma Serum Repository Protocol
Status: Archived
Updated: 1/1/1970
Welch Cancer Center
mi
from
Sheridan, WY
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1, Multi-Center, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Archived
mi
from
Rochester, MN
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1, Multi-Center, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1, Multi-Center, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Archived
mi
from
Hackensack, NJ
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
A Phase 1, Multi-Center, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Status: Archived
Updated: 1/1/1970
Hackensack University
mi
from
Hackensack, NJ
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Birmingham, AL
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Duarte, CA
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
City of Hope Medical Canter
mi
from
Duarte, CA
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Los Angeles, CA
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Detroit, MI
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
Wayne State University/Detroit Medical Center
mi
from
Detroit, MI
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Rochester, MN
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
New York City, NY
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
Memorial Sloan Kettering
mi
from
New York City, NY
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Nashville, TN
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
Sarah Cannon Cancer Center
mi
from
Nashville, TN
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
mi
from
Seattle, WA
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of SGN-75 in Patients With CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Donor Lymphocytes in Preventing and Treating Cytomegalovirus Infection or Adenovirus Infection in Patients Who Have Undergone Umbilical Cord Blood Transplant
Adoptive Transfer of Cord Blood T Cells to Prevent and Treat CMV and Adenovirus Infections After Transplantation
Status: Archived
mi
from
Houston, TX
Donor Lymphocytes in Preventing and Treating Cytomegalovirus Infection or Adenovirus Infection in Patients Who Have Undergone Umbilical Cord Blood Transplant
Adoptive Transfer of Cord Blood T Cells to Prevent and Treat CMV and Adenovirus Infections After Transplantation
Status: Archived
Updated: 1/1/1970
Dan L. Duncan Cancer Center at Baylor College of Medicine
mi
from
Houston, TX
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma Who Are at Risk for Relapse After High Dose Chemotherapy and Autologous Stem Cell Transplant
Status: Archived
mi
from
Los Angeles, CA
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma Who Are at Risk for Relapse After High Dose Chemotherapy and Autologous Stem Cell Transplant
Status: Archived
Updated: 1/1/1970
UCLA Medical Center
mi
from
Los Angeles, CA